0001168404-22-000004.txt : 20221208 0001168404-22-000004.hdr.sgml : 20221208 20221207204326 ACCESSION NUMBER: 0001168404-22-000004 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20221208 DATE AS OF CHANGE: 20221207 EFFECTIVENESS DATE: 20221208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ACHIEVE LIFE SCIENCES, INC. CENTRAL INDEX KEY: 0000949858 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 954343413 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-465960 FILM NUMBER: 221451271 BUSINESS ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 BUSINESS PHONE: 425-686-1500 MAIL ADDRESS: STREET 1: 22722 29TH DR. SE STREET 2: SUITE 100 CITY: SEATTLE STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: ONCOGENEX PHARMACEUTICALS, INC. DATE OF NAME CHANGE: 20080821 FORMER COMPANY: FORMER CONFORMED NAME: SONUS PHARMACEUTICALS INC DATE OF NAME CHANGE: 19950825 D/A 1 primary_doc.xml X0708 D/A LIVE 0000949858 ACHIEVE LIFE SCIENCES, INC. 1040 West Georgia Suite 1030 Vancouver, B.C. A1 BRITISH COLUMBIA, CANADA V6E 4H1 604-210-2217 DELAWARE ONCOGENEX PHARMACEUTICALS, INC. SONUS PHARMACEUTICALS INC Corporation true John Bencich c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Executive Officer Director Cindy Jacobs c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Executive Officer Director Anthony Clarke c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Executive Officer Jaime Xinos c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Executive Officer Richard Stewart c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Director Bridget Martell c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Director Vaughn Himes c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Director Donald Joseph c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Director Jay Moyes c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Director Martin Mattingly c/o Achieve Life Sciences, Inc. 1040 West Georgia, Suite 1030 Vancouver A1 BRITISH COLUMBIA, CANADA V6E 4H1 Director Biotechnology Decline to Disclose 06b true 0001168404-22-000003 2022-11-18 false true Units consisting of two shares of common stock and one common stock warrant. false 0 25000000 18900000 6100000 false 16 0 756000 0 false ACHIEVE LIFE SCIENCES, INC. /s/ John Bencich John Bencich Chief Executive Officer 2022-12-07